Business Description
Ernexa Therapeutics Inc. is a Cambridge, Massachusetts-based company founded in 2018 that creates stem cell-based treatments for cancer and autoimmune conditions. Its two lead programs use specially engineered stem cells to either attack tumors in ovarian cancer or calm harmful immune responses in rheumatoid arthritis. The company, formerly known as Eterna Therapeutics Inc., operates under a licensing agreement with Factor Bioscience Limited and changed its name in March 2025.
